The research report entitled “Legal global cannabis market by product type (cannabis flowers, cannabis extracts), species (Sativa, Indica), strains (THC, CBD), purchasing channel, application (medical, recreational), end industries and geography – Global forecast to 2025” provides an in-depth analysis of the local cannabis market in five major geographical locations and highlights current market trends, volume and share; recent developments; and projections until 2025.
Since CBD can be obtained from hemp, which does not contain significant amounts of THC, CBD is virtually legal in most states. Although they issue more and more CBD regulations.
State-of-the-art 140-acre industrial farm
Many of these companies situated themselves in Colorado, such as Veritas Farms Inc. (OTC: VFRM) which owns a state-of-the-art 140-acre industrial hemp farm and manufacturing facility in Pueblo, Colorado. The company registered with the Colorado Department of Agriculture to grow industrial hemp.
The company’s strategy bases itself around transparency, honesty and high-quality products. They control their own supply chain which allows them to provide a fully transparent product. Recently, the company launched a QR code packaging thanks to which customers can check the quality of the product with their smartphones.
Legalized cannabis may generate 105.6 billion dollars of tax revenue
The report published yesterday “analyses how legal cannabis can generate tax revenues and new jobs for the US economy.” New data published by New Frontier Data predict that if all states in the USA legalized cannabis, by 2025 they would have generated 105.6 billion dollars of tax revenue and a million new jobs.
The report analyses three aspects of the full legalization of cannabis, as well as the expected impact on the US economy. If all 50 states were to legalize cannabis, the number of new jobs would increase to 1 million in 2025.
Full legalization would result in more companies entering the market, more consumers and more employees on official payrolls. As a result, leading to $3.3 billion in revenue from payroll taxes alone.
The growing medical use of cannabis
The growth in this market is mainly due to the increasing legalization of cannabis, the growing medical use of cannabis. Furthermore, the growing number of elderly people who need cannabis to treat chronic diseases.
However, high costs and strict rules on the production, distribution, sale, and possession of legal cannabis to some extent hinder the development of this market.
The global medical cannabis market has enormous potential, with experts predicting significant growth between 2019 and 2025. Besides, continuous research into medical cannabis applications is accelerating the growth of the cannabis market.
An increase in the number of countries approving the use of cannabis for therapeutic purposes. Those are the treatment of pain in cancer and HIV/AIDS patients, appetite stimulator and nausea reduction. This is expected to drive the global medical cannabis market.
(Featured image by Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. B2I assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. B2I is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Historic boom for Lysogene biotech to the U.S. market
The shares of Lysogene, a biopharmaceutical company, has risen by more than 50% thanks to the granted "Fast Track" designation...
Crowdfunding in Mexico: the financial alternative of 2020
Crowdfunding in Mexico has been handled in a less obvious way for hundreds of years. Crowdfunding refers to any capital...
Aena appeals against the CNMC’s imposition of further fare reductions on airlines
The CNMC has approved the Resolution on the supervision of airport tariffs applicable by Aena in the year 2020, in...
Victim lost $5000 in a false Nubank employee scam
A 46-year-old assistant approached the Judiciary Police Central of Americana on February 18, reporting that he lost more than $5.000...
Kafo Jiginew and the EIB loan agreement estimates at $10.8 billion
The signing of a loan agreement for $10.8 billion between "Kafo Jiginew" and the European Investment Bank. It was chaired...